ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

October 21, 2005

NCI May Support More Training Of Cancer Surgeons

May 23, 1975

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002